Dr. Öğr. Üyesi MERVE ÇEBİ

Yayın Ağı

Makaleler 8

1. Cytokine Profiles in Myasthenia Gravis Subgroups and the Lack of Any Effect of Immunosuppression

Cebi M., Durmus H., Cakar A., Gunver M. G., Parman Y., Deymeer F., et al.

MUSCLE & NERVE , 2026 (SCI-Expanded, Scopus)

2. Effect of CXCR5, PD-1 and ICOS on B-cell responses and relevance to myasthenia gravis

Cebi M., Cakar A., Durmus H., Parman Y., Saruhan-Direskeneli G.

CLINICAL & TRANSLATIONAL IMMUNOLOGY , cilt.15, sa.6, 2026 (SCI-Expanded, Scopus)

3. Epithelial barrier hypothesis in the context of nutrition, microbial dysbiosis, and immune dysregulation in metabolic dysfunction-associated steatotic liver

Çebi M., Yılmaz Y.

FRONTIERS IN IMMUNOLOGY , cilt.16, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

4. In vitro modulation of T cells in myasthenia gravis by low-dose IL-2

Cebi M., ÇAKAR A., DURMUŞ TEKÇE H., Akan O., Aysal F., Parman Y., et al.

EUROPEAN JOURNAL OF IMMUNOLOGY , cilt.54, sa.11, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

5. Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: unveiling the critical role of T and B lymphocytes

Çebi M., Yılmaz Y.

FRONTIERS IN IMMUNOLOGY , cilt.15, 2024 (SCI-Expanded, Scopus)

6. Thymoma patients with or without myasthenia gravis have increased Th17 cells, IL-17 production and ICOS expression

Cebi M., Cakar A., Erdogdu E., Durmus-Tekce H., Yegen G., Ozkan B., et al.

JOURNAL OF NEUROIMMUNOLOGY , cilt.381, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. CD4⁺ T Cells of Myasthenia Gravis Patients Are Characterized by Increased IL-21, IL-4, and IL-17A Productions and Higher Presence of PD-1 and ICOS

Çebi M., Durmus H., Aysal F., Özkan B., Gül G. E., Çakar A., et al.

FRONTIERS IN IMMUNOLOGY , cilt.11, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. **Relation of HLA-DRB1 to IgG4 autoantibody and cytokine production in muscle-specific tyrosine kinase myasthenia gravis (MuSK-MG)**

Çebi M., Durmuş H., YILMAZ V., Yentür S., Aysal F., Oflazer P., et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY , cilt.197, sa.2, ss.214-221, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

114

H-İndeks (WoS)

Atıf (Scopus)

116

H-İndeks (Scopus)

Toplam Atıf Sayısı